Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Dermatology

Symptoms and Triggers: Why It Happens and What to Watch For

At a Glance

Cutaneous small vessel vasculitis (CSVV) causes palpable purpura, which are raised, purple spots primarily on the lower legs. It can be triggered by infections or medications. If you experience abdominal pain, bloody urine, or severe joint pain, contact your doctor immediately.

The most striking feature of Cutaneous Small Vessel Vasculitis (CSVV) is the appearance of the skin, but understanding why the rash looks the way it does and identifying what might have caused it are the first steps toward management [1][2].

The Signature Symptom: Palpable Purpura

The classic symptom of CSVV is palpable purpura—raised, purple-red spots that do not turn white (blanch) when you press on them [3][2]. Unlike a flat heat rash or a bruise, you can actually feel these spots with your fingertips because they are caused by active inflammation and swelling in the vessel walls [4][2].

These spots most often appear on the lower legs, ankles, and feet [4][3]. This specific location is not a coincidence; it is caused by:

  • Hydrostatic Pressure: This is the pressure exerted by blood against the walls of the vessels. Because of gravity, the blood pressure in your leg veins is higher than in other parts of your body when you are standing or sitting [5].
  • Vessel Vulnerability: The combination of gravity and high pressure makes it easier for immune complexes to get “pushed” into the small vessel walls of the lower legs, where they trigger the inflammatory response [5][6].

Common Triggers

In about half of all cases, a specific trigger can be identified that “tripped” the immune system into overreacting [7][8]. These triggers usually occur 2 to 4 weeks before the rash appears [9].

1. Infections
Your body’s attempt to fight off a germ can sometimes lead to “friendly fire” against your blood vessels. Common links include:

  • Bacteria: Streptococcal pharyngitis (Strep throat) [10][11].
  • Viruses: SARS-CoV-2 (COVID-19), Hepatitis B, Hepatitis C, Hepatitis E, and sometimes even the flu. Hepatitis B and C, in particular, are classic triggers that can cause systemic inflammation [12][13][14].

2. Medications
Many drugs can inadvertently trigger CSVV. Some of the most common include:

  • Antibiotics: Especially “sulfa” drugs (sulfamethoxazole-trimethoprim) and cephalosporins [15][16].
  • Anticoagulants (Blood Thinners): Specifically a class called DOACs (like apixaban or rivaroxaban) [17][18].
  • NSAIDs: Common over-the-counter pain relievers like ibuprofen or naproxen [19]. Note: Because NSAIDs can be a trigger, ask your doctor before taking them for joint or rash pain. Acetaminophen (Tylenol) is often recommended as a safer alternative.

3. Underlying Conditions
Sometimes the vasculitis is a symptom of another condition, such as Inflammatory Bowel Disease (IBD), lupus, or other autoimmune diseases [20][21].

Note on “Idiopathic” Cases: In approximately 50% of patients, no clear trigger is ever found [7][22]. Doctors call this idiopathic CSVV [23]. If your tests come back normal and no trigger is found, it is considered a common and normal part of this diagnosis [22][8].

Systemic Red Flags

While most CSVV only affects the skin, it is vital to watch for signs that the inflammation is occurring inside the body. These “red flags” suggest that internal organs, such as the kidneys or gastrointestinal tract, may be involved:

  • Abdominal Pain: Severe stomach pain, nausea, or vomiting can indicate inflammation in the gut [1][24].
  • Changes in Waste: Blood in the stool or urine (which may look red, pink, or tea-colored) is a sign that the small vessels in the intestines or kidneys are affected [25][26].
  • Severe Joint Pain: Known as polyarthralgia, significant swelling or pain in the joints (especially the knees and ankles) is a common sign of systemic involvement [24].
  • Constitutional Symptoms: Unexplained fever, extreme fatigue (malaise), or night sweats [27][28].

If you experience any of these red flags, you should notify your doctor immediately, as they may change your management plan from “skin-only” care to more intensive treatment [1][29]. You can learn more about how your doctor investigates these red flags in The Diagnostic Journey.

Common questions in this guide

Why does the CSVV rash usually appear on the lower legs and feet?
Gravity and higher blood pressure in the leg veins push immune complexes into the small vessel walls of the lower legs. This combination makes these vessels more vulnerable to inflammation, resulting in the characteristic purple spots.
Can medications cause cutaneous small vessel vasculitis?
Yes, certain medications can trigger an overactive immune response leading to CSVV. Common culprits include antibiotics like sulfa drugs, blood thinners, and over-the-counter NSAIDs like ibuprofen.
What does it mean if my doctor says my CSVV is idiopathic?
If your CSVV is considered idiopathic, it means no specific trigger, such as an infection or medication, could be identified. This is a very common diagnosis and occurs in approximately half of all patients with this condition.
What are the red flag symptoms of CSVV that I should watch for?
While CSVV primarily affects the skin, inflammation can sometimes involve internal organs. You should seek immediate medical attention if you develop severe abdominal pain, blood in your stool or urine, extreme joint pain, or an unexplained fever.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that my rash is mostly on my legs, is that consistent with the role of gravity you've seen in other patients?
  2. 2.Could any of the specific medications I started in the last month be the 'offending agent' for this vasculitis?
  3. 3.If we can't find a specific trigger, does that mean my case is considered idiopathic?
  4. 4.What specific signs in my blood work or urinalysis should we look for to rule out kidney involvement?
  5. 5.If I develop stomach pain or joint swelling, how quickly should I contact your office?
  6. 6.What over-the-counter pain medications are safe for me to take, given that NSAIDs can sometimes be a trigger?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (29)
  1. 1

    Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management.

    Micheletti RG

    American journal of clinical dermatology 2023; (24(1)):89-95 doi:10.1007/s40257-022-00736-6.

    PMID: 36308673
  2. 2

    Leukocytoclastic vasculitis: An uncommon adverse effect of a common drug.

    Sheoran A, Mahto SK, Verma P, et al.

    Journal of family medicine and primary care 2019; (8(6)):2137-2139 doi:10.4103/jfmpc.jfmpc_338_19.

    PMID: 31334194
  3. 3

    Vasculitis in the setting of COVID-19: From the disease to the vaccine. Report of a case of cutaneous vasculitis after immunization.

    Criado PR, Giordani LP, Yoshimoto TA, et al.

    Dermatologic therapy 2022; (35(5)):e15367 doi:10.1111/dth.15367.

    PMID: 35141989
  4. 4

    Dermatologic Diagnosis: Leukocytoclastic Vasculitis.

    Einhorn J, Levis JT

    The Permanente journal 2015; (19(3)):77-8 doi:10.7812/TPP/15-001.

    PMID: 26176572
  5. 5

    A detailed analysis of the distribution, morphology, and histopathology of complex purpura in hospitalized patients: A case series of 68 patients.

    Gehlhausen JR, Wetter DA, Nelson C, et al.

    Journal of the American Academy of Dermatology 2021; (84(4)):1188-1196 doi:10.1016/j.jaad.2020.04.149.

    PMID: 32376433
  6. 6

    A case of erythema elevatum diutinum after COVID-19 vaccination.

    Muna B

    Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(9)):e1102-e1103 doi:10.1111/jdv.19188.

    PMID: 37170942
  7. 7

    Leukocytoclastic Vasculitis Induced by Cocaine Adulterated with Levamisole.

    Barbotti A, Gheorghiu AC, Fusi-Schmidhauser T, Grazioli-Gauthier L

    European journal of case reports in internal medicine 2022; (9(7)):003468 doi:10.12890/2022_003468.

    PMID: 36051168
  8. 8

    Dermatologic Aspects of Systemic Vasculitis.

    Younger DS, Carlson A

    Neurologic clinics 2019; (37(2)):465-473 doi:10.1016/j.ncl.2019.01.017.

    PMID: 30952419
  9. 9

    Cutaneous leukocytoclastic vasculitis leading to extensive digital necrosis as the only COVID-19 clinical manifestation.

    Pouy R, Bermejo M, Durlach A, Bani-Sadr F

    Vascular diseases (Paris, France) 2026; (51(2)):97-99 doi:10.1016/j.vasdi.2025.12.003.

    PMID: 41577611
  10. 10

    Cutaneous necrotizing small-vessel vasculitis induced by acute hepatitis E.

    Viallard JF, Vergier B, Lazaro E, et al.

    Clinical case reports 2019; (7(8)):1539-1541 doi:10.1002/ccr3.2167.

    PMID: 31428384
  11. 11

    Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains.

    Rhodes RH, Love GL, Da Silva Lameira F, et al.

    Diagnostic pathology 2024; (19(1)):33 doi:10.1186/s13000-024-01445-w.

    PMID: 38360666
  12. 12

    Exuberant bullous vasculitis associated with SARS-CoV-2 infection.

    Gouveia PADC, Cipriano IC, de Melo MAZ, et al.

    IDCases 2021; (23()):e01047 doi:10.1016/j.idcr.2021.e01047.

    PMID: 33457205
  13. 13

    Very Early-Onset Inflammatory Bowel Disease (VEO-IBD) Presenting with Recurrent Leukocytoclastic Vasculitis Preceded by Streptococcal Pharyngitis.

    Fonseca A, Sunny J, Felipez LM

    Case reports in pediatrics 2021; (2021()):1996430 doi:10.1155/2021/1996430.

    PMID: 34104503
  14. 14

    An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient.

    Negrini S, Guadagno A, Greco M, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(11)):e675-e676 doi:10.1111/jdv.16760.

    PMID: 32558979
  15. 15

    Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

    Mohamoud M, Horgan C, Eworuke E, et al.

    Pharmacotherapy 2020; (40(11)):1099-1107 doi:10.1002/phar.2468.

    PMID: 33090530
  16. 16

    Levetiracetam-induced leukocytoclastic vasculitis.

    Gupta M

    Indian journal of pharmacology 2017; (49(1)):124-126 doi:10.4103/0253-7613.201020.

    PMID: 28458437
  17. 17

    Cutaneous leukocytoclastic vasculitis induced by thiamazole.

    Sato A, Takemori C, Fukumoto T, et al.

    The Journal of dermatology 2021; (48(12)):e604-e605 doi:10.1111/1346-8138.16205.

    PMID: 34687061
  18. 18

    Cefazolin as a cause of leukocytoclastic vasculitis.

    Ali N, Karia N, Goldhahn R

    Clinical case reports 2017; (5(6)):1051-1053 doi:10.1002/ccr3.992.

    PMID: 28588872
  19. 19

    Leukocytoclastic vasculitis caused by sulfamethoxazole-trimethoprim.

    Bhatt P, Montreuil N, Olayiwola A, et al.

    Clinical case reports 2024; (12(2)):e8437 doi:10.1002/ccr3.8437.

    PMID: 38314186
  20. 20

    Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.

    Fiorillo G, Pancetti S, Cortese A, et al.

    Journal of autoimmunity 2022; (127()):102783 doi:10.1016/j.jaut.2021.102783.

    PMID: 34973526
  21. 21

    Etiologies and prognostic factors of leukocytoclastic vasculitis with skin involvement: A retrospective study in 112 patients.

    Bouiller K, Audia S, Devilliers H, et al.

    Medicine 2016; (95(28)):e4238 doi:10.1097/MD.0000000000004238.

    PMID: 27428231
  22. 22

    Leukocytoclastic Vasculitis Masquerading as Chronic Idiopathic Thrombocytopenic Purpura.

    Tasnim S, Yousuf H, Al-Hilli Y, et al.

    Federal practitioner : for the health care professionals of the VA, DoD, and PHS 2022; (39(11)):e0337 doi:10.12788/fp.0337.

    PMID: 36582494
  23. 23

    A case of leukocytoclastic vasculitis caused by novel anticoagulant rivaroxaban.

    Dean R, Messer AM, Pickett M, Jahan-Tigh R

    Dermatology online journal 2017; (23(11)).

    PMID: 29447643
  24. 24

    Widespread cutaneous small vessel vasculitis secondary to COVID-19 infection.

    Tahir A, Sohail Z, Nasim B, Parmar NV

    International journal of dermatology 2020; (59(10)):1278-1279 doi:10.1111/ijd.15106.

    PMID: 32880974
  25. 25

    Cephalexin-Induced Leukocytoclastic Vasculitis.

    Tang W, Tan J

    Cureus 2022; (14(7)):e26545 doi:10.7759/cureus.26545.

    PMID: 35936130
  26. 26

    A Cross-Sectional Study to Correlate Serum Complement C3 and C4 Levels With Clinical and Pathological Severity in Cutaneous Small-Vessel Vasculitis.

    Sarkar N, Palit A, Sethy M, et al.

    Cureus 2022; (14(5)):e24845 doi:10.7759/cureus.24845.

    PMID: 35693365
  27. 27

    Secondary syphilis presenting as leukocytoclastic vasculitis in a 61-year-old man.

    Mohamed N, Dacy NN, Lopez LM, Bicknell LM

    Dermatology online journal 2023; (29(5)) doi:10.5070/D329562402.

    PMID: 38478638
  28. 28

    Early diagnosis and treatment of Leukocytoclastic Vasculitis: case report.

    Bezerra AS, Polimanti AC, de Oliveira RA, et al.

    Jornal vascular brasileiro 2020; (19()):e20180072 doi:10.1590/1677-5449.190072.

    PMID: 31975988
  29. 29

    Recommendations for the diagnostic work-up of cutaneous small vessel vasculitis - Position Statement of the European Academy of Dermatology and Venereology Vasculitis and Vasculopathy Task Force.

    Alpsoy E, Caproni M, Wetter DA, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2026; (40(6)):946-962 doi:10.1111/jdv.70249.

    PMID: 41399325

This page provides educational information about CSVV symptoms and triggers. Always consult your healthcare provider to evaluate any new rashes or systemic symptoms.

Get notified when new evidence is published on Cutaneous small vessel vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.